imricor vision mr
Feature

Imricor Medical Systems, Inc. announced the first three cardiac ablation procedures were completed in the first clinical study that is evaluating the feasibility of their magnetic resonance (MR)-enabled products to treat atrial flutter. Prof. Reza Razavi, head of the Division of Imaging Sciences and Biomedical Engineering, King's College London, is the principal investigator for the study and performed the procedures along with Mark O'Neill, professor of cardiac electrophysiology and consultant cardiologist, Guy's and St. Thomas' NHS Trust in the United Kingdom, The prospective pilot study will enroll up to 15 patients at this center.

Home October 15, 2014
Home
News

October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.

Home October 15, 2014
Home
News

October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its investigational heart failure medicine, LCZ696, was superior to the ACE-inhibitor enalapril on key endpoints. The results were released at the 2014 European Society of Cardiology (ESC) Congress and published simultaneously in the New England Journal of Medicine.

Home October 15, 2014
Home
News

October 15, 2014 — Imaging can be a cost-effective way to identify people at risk for stroke who might benefit from aggressive intervention, according to a new modeling study published online in the journal Radiology.

Home October 15, 2014
Home
Impact of Mental Stress on Heart Varies Between Men, Women ACC Study
Feature

Men and women have different cardiovascular and psychological reactions to mental stress, according to a study of men and women who were already being treated for heart disease.

Home October 15, 2014
Home
News

The Geneva Healthcare Suite has been proven effective by clinicians at the Douglas & Nancy Barnhart Cancer Center at Sharp Chula Vista Medical Center in managing risk for patients with cardiac devices undergoing radiation therapy.

Home October 15, 2014
Home
Technology

Healthline today launched its HealthData Engine to harness the power of structured and unstructured data to improve outcomes and reduce costs. The new big-data analytics platform leverages the company’s HealthTaxonomy advanced clinical natural language processing (NLP) technologies and semantic analysis to turn patient data into actionable insights.

Home October 14, 2014
Home
X0000_GE_ Customer using the Intel-GE Care Innovations Guide.
Feature

In partnership with Intel-GE Care Innovations, Cigna-HealthSpring is expanding its population health program that utilizes interactive tablets – the Intel-GE Care Innovations Guide – and virtual connection to Cigna-HealthSpring nurse practitioners to partner and engage with patients diagnosed with congestive heart failure (CHF) to successfully manage their condition at home. Based on a successful pilot in Middle Tennessee that engaged 50 patients, the innovative remote patient management program is now being implemented with 250 patients statewide with potential for further expansion.

Home October 14, 2014
Home
News

Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating and preventing heart failure. The newly discovered molecule provides the heart with a tool to block a protein that orchestrates genetic disruptions when the heart is subjected to stress, such as high blood pressure.

Home October 14, 2014
Home
News

Although the highly saturated picture archiving and communication systems (PACS) segment is slowing growth in the U.S. imaging informatics market, a few niche areas are advancing forming new growth areas.

Home October 14, 2014
Home
Technology

The U.S. Food and Drug Administration (FDA) approved Lumason (sulfur hexafluoride lipid microsphere) for patients whose ultrasound image of the heart (echocardiograms) are hard to see with ultrasound waves.

Home October 14, 2014
Home
News

Infraredx Inc. announced that its dual-modality intravascular imaging technology, TVC Imaging System, and its TVC Insight Catheter received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW).

Home October 14, 2014
Home
News

Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference, the latest clinical and economic data on the IN.PACT Admiral drug-coated balloon (DCB) from Medtronic Inc. augments an already robust body of evidence that continues to drive a reconsideration of the standard of care for peripheral artery disease (PAD) in leg arteries above the knee.

Home October 14, 2014
Home
News

Covidien announced that it has notified customers of a voluntary Field Safety Alert for certain Medi-Trace Cadence and Kendall Multi-function Defibrillation Electrodes due to a connector compatibility issue with Philips FR3 and FRx defibrillators.

Home October 13, 2014
Home
News

October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman left atrial appendage (LAA) closure device, the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted in favor of the device. By a vote of 6 to 5 (with 1 abstention) the panel concluded the benefits of the Watchman device outweigh the potential risks.

Home October 13, 2014
Home
Subscribe Now